Belite Bio, Inc (BLTE)
NASDAQ: BLTE · IEX Real-Time Price · USD
43.20
+2.09 (5.08%)
May 3, 2024, 4:00 PM EDT - Market closed
Belite Bio Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
20
Market Cap
1.29B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 0 | - | - |
Dec 31, 2022 | 0 | - | - |
Dec 31, 2021 | 0 | - | - |
Dec 31, 2020 | 0 | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionBLTE News
- 2 days ago - Belite Bio Announces Presentation at the Association for Research in Vision and Ophthalmology 2024 Annual Meeting - GlobeNewsWire
- 8 days ago - Belite Bio Announces $25 Million Registered Direct Offering - GlobeNewsWire
- 6 weeks ago - Belite Bio Announces PMDA Submission of Tinlarebant for Stargardt Disease Clinical Trial in Japan - GlobeNewsWire
- 7 weeks ago - Belite Bio Announces Availability of Annual Report on Form 20-F Through Company Website - GlobeNewsWire
- 7 weeks ago - Belite Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update - GlobeNewsWire
- 2 months ago - Belite Bio to Host Webcast on March 12, 2024, to Discuss Fourth Quarter and Full Year 2024 Financial Results - GlobeNewsWire
- 2 months ago - Belite Bio to Participate in the Leerink Partners Global Biopharma Conference - GlobeNewsWire
- 3 months ago - Belite Bio to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference - GlobeNewsWire